New microÂincision IOL yields promising results
The new Microincision Incise™ IOL™(Bausch and
Lomb) provides good visual outcomes and good
capsular stability, Antonio Toso MD Bassiano
Hospital, Bassano del Grappa (VI), Italy Italy, told the 18th ESCRS Winter Meeting in Ljubjana, Slovenia.
“The lens can be implanted through 1.8 mm in the
bag, providing excellent visual and refractive
outcomes," he said.
He presented the preliminary results achieved in
25 eyes of 25 patients implanted with the new lens
at his centre as part of a multicentre FDA trial. The
patients had a mean age was 72.0 years. All
underwent sub2.0 2.0 MICS and implantation of
an Incise™ IOL through an 1.8 mm incision using
the Viscoject 1.5™ IOL inserter.
After a followup period ranging from four to six
months uncorrected visual acuity ranged from
20/32 to 20/25 and had a mean value of 0.156
logMAR. In addition, mean corrected distance
visual acuity was 20/20. Furthermore, mean
manifest refractive spherical equivalent was 0.28.
Furthermore, absolute total centration as measured
by digital slit lamp biomicroscopy was 0.29 mm,
statistically comparable with that achieved with
conventional one or threepiece IOLs, which
typically have a centration of 0.2 mm to 0.6 mm.
He noted that the Incise IOL is a onepiece lens is
composed of an enhanced hydrophilic material with
22 per cent water content. It has an aberrationfree
sharp posterior edged optic with a diameter of 6.0
mm. Its overall length is of 11.0 mm. It has four
” told the 18th Congress of the ESCRS in
fenestrated angulated haptics.
He added that longterm results will be evaluated to
assess the posterior capsule opacification.
END